BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
about
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugsEmerging roles of extracellular vesicles in the nervous systemProteomic Substrate Identification for Membrane Proteases in the BrainPMEL Amyloid Fibril Formation: The Bright Steps of PigmentationA tale of two drug targets: the evolutionary history of BACE1 and BACE2Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitorsPhysiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in Fonsecaea pedrosoi.The refractive state of the eye in Icelandic horses with the Silver mutation.Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes.Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.Targeting the β secretase BACE1 for Alzheimer's disease therapy.Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors.A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.Microtubule-associated protein light chain 3 is involved in melanogenesis via regulation of MITF expression in melanocytesThe Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation.Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice.Design of Potent and Highly Selective Inhibitors for Human β-Secretase 2 (Memapsin 1), a Target for Type 2 Diabetes.Melanosomal formation of PMEL core amyloid is driven by aromatic residues.Amyloid-based nanosensors and nanodevices.BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing MicrohemorrhageStudy of Exosomes Shed New Light on Physiology of Amyloidogenesis.The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.On the evolutionary trajectories of signal-transducing amyloids in fungi and beyond.Amyloids, melanins and oxidative stress in melanomagenesis.Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality.Why are Functional Amyloids Non-Toxic in Humans?Meeting after meeting: 20 years of discoveries by the members of the Exocytosis-Endocytosis Club.Expression of skin color genes in lymphocytes of Karan Fries cattle and seasonal relationship with tyrosinase and cortisol.Mechanical properties of amyloid-like fibrils defined by secondary structures.Analyzing Lysosome-Related Organelles by Electron Microscopy.Amyloid assembly and disassemblyRab4A organizes endosomal domains for sorting cargo to lysosome-related organelles
P2860
Q26740189-6F53617C-8407-44FB-B7CF-582A74B75288Q27025173-3C4E9039-54FA-4A0E-9A56-7368D373360AQ28069428-BABE158F-A18B-44A3-B8E1-8546BCEB07CBQ28076932-8B9B4BA4-4814-41AE-8318-1CC4617D17FEQ28661086-E27E6DA7-EFA8-4C1F-A4D2-0F768A44C4C3Q28822108-734CD06B-AB1D-428A-BEA8-2C79E01235ACQ33575863-DAEB53ED-43CE-4995-B22C-A784CFFC1698Q33705209-6A0EBB59-143E-4CCF-936E-ECD9CC5AC8AFQ33755739-6D137C5D-B77E-4D7D-83E6-FD9792785A85Q33810200-F306BCE4-C99A-4BFA-98DF-E47CB6A50D2DQ33862796-6EEBBA89-D599-42B2-913A-B8A9FE64D1FEQ34405667-EDE8E75C-C0BC-4249-A056-242DB3EC36F1Q35972878-464D6122-068C-41CA-9B73-251D08B6F991Q36027275-EBA1B3B3-4C26-4499-9D84-00EF7CDD63F0Q36507367-0E92F292-FC40-4355-8526-A13F9C5A03A7Q36574029-56B5D6B2-7024-4630-B977-0D72DA754953Q36615914-B1DFCBE2-0EE7-4AE8-A2D3-CCD3C16AE676Q37028575-D638A20B-7CEF-4AA6-9F92-1BB879755626Q37685780-C4AE0EB9-98A6-4B55-B0C3-2F048419BB7AQ38208186-1FD9B962-7DFB-4BA1-865F-869129AD1208Q38332419-AE7CC02E-2FFB-445F-B801-CB8581310D38Q38628808-D6E43F58-4DE3-4D05-8848-BF441862A11AQ38777380-EE6D83C6-96EB-482D-A760-3798AE9BBA49Q39222469-5E197FB8-C8F6-4DD3-85AB-5D3CCC6F4AB7Q41622293-15ACC438-F3EB-4235-AF95-A9C4889B9A20Q41717134-9B8787C1-3B13-4FDF-9780-9B548E4CDEA8Q42089651-C3176CBC-EA2A-463B-A6B0-769197637943Q44607866-BD411175-F938-4D7A-ACF5-EB75473B3715Q46134175-AF22E842-0F64-461A-8325-94E6B5CE1806Q46302841-77C179F0-43F0-4730-93EB-FA52A09B40D5Q47200632-B94FB002-1E6F-4778-AA25-B62EAC8A183EQ50674288-C3F97CFF-9A49-49A6-BE39-088EFE473D2AQ53558654-302B63B5-026A-48F8-A8DE-38D18B74A050Q53778201-2F437B08-A219-4923-8C4B-3DDD3831D4D3Q58621641-7B6F436D-9618-4668-ACC7-6E6EF79AED0AQ58711097-E6753CE9-E39D-466C-BEDE-43606D7CE7C4
P2860
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
@en
type
label
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
@en
prefLabel
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
@en
P2093
P2860
P50
P356
P1476
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells.
@en
P2093
Brenda Watt
Cecile Fort
Graça Raposo
Ilse Hurbain
Leila Rochin
Lutgarde Serneels
Michael S Marks
Pascal Leblanc
P2860
P304
10658-10663
P356
10.1073/PNAS.1220748110
P407
P577
2013-06-10T00:00:00Z